United States · FDA National Drug Code directory

Irritable Bowel Syndrome Therapy

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 17312-019_46052231-af53-3dfd-e063-6394a90a71ff
Product NDC: 17312-019
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT -
Labeler: TRP Company
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20111201
Source listing expiry: 20261231

Source-listed ingredients

ASAFETIDA — 3 [hp_X]/1
BISMUTH SUBNITRATE — 6 [hp_X]/1
BRYONIA ALBA ROOT — 6 [hp_X]/1
ACTIVATED CHARCOAL — 6 [hp_X]/1
LYCOPODIUM CLAVATUM SPORE — 6 [hp_X]/1
SODIUM CARBONATE — 6 [hp_X]/1
STRYCHNOS NUX-VOMICA SEED — 6 [hp_X]/1
VERATRUM ALBUM ROOT — 6 [hp_X]/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 PACKAGE (17312-019-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-019-14

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →